SpendMend Recognized as Top Recovery Auditing Firm in Healthcare
SpendMend earns top honors for Recovery Auditing, for the second consecutive year, in the annual Corporate Excellence Awards
SpendMend SpendMend …
Read MoreAdvertising Press Release Distribution | Reality TV | Lifestyle Magazine | Kiev Plastic Surgery
SpendMend earns top honors for Recovery Auditing, for the second consecutive year, in the annual Corporate Excellence Awards
SpendMend SpendMend …
Read More
As facilities continue to face major cleaning staff shortages, this product helps take the worry away by targeting and eliminating odors.
SARASOTA, Fla. – December 13, 2022 – (Newswire.com)
The COVID-19 pandemic forced the hospitality industry to lay off millions of workers, and many have not returned. The sector’s employment is down nearly 1 million workers as of November 2022, and 97% of hotels now report staffing shortages in 2022. Hotels and other residential facilities, like assisted living and nursing homes now lack the staff to effectively manage cleaning issues like persistent odors. EcoClear Products, a company dedicated to providing 100% safe alternatives to harmful rodenticides, insecticides, and cleaning solutions, has developed ProBio® OdorOut®, a product that can help solve this issue.
ProBio® OdorOut® is an odor eliminator that targets and eliminates all nitrogen-based odors, like urine, feces and vomit, for example. While other products mask the scent, ProBio® OdorOut® destroys it through a patented process called spontaneous oxidation-reduction (SOR), which eliminates odor molecules on contact.
“ProBio® OdorOut® is formulated with no bacteria or enzymes, meaning it’s biodegradable and safe for use around people,” said Christopher Stidd, founder of EcoClear Products. “With the often difficult workload that comes with cleaning a room and caring for people, odor elimination should be the last thing these sectors should have to worry about, and this product helps address the issue.”
Odors stemming from incontinence, dumpsters and restrooms can play a significant role in a person’s decision to stay at a facility long-term – whether it’s a hotel or an assisted living facility. Cleaning agents also typically have a harsh scent that can be off-putting for most. ProBio® OdorOut® also has no shelf life, so it will consistently work no matter how old the product is.
EcoClear Products uses patented and proprietary compounds and processes that have won four Presidential Awards for “green” chemistry. The chemists on the EcoClear Products team are passionate about creating innovative offerings and have extensive experience in pesticides, rodenticides, detergents and food supply. The company also continues to expand its offerings of green cleaning and odor-neutralizing products for homes and businesses.
To learn more, visit www.ecoclearproducts.com/pro.
About EcoClear Products
EcoClear Products is dedicated to innovating effective pest and rodent control products that are safe for use around people, pets, livestock and wildlife. The EcoClear team’s chemists are passionate about creating environmentally conscious products and have received four Presidential Green Chemistry awards. EcoClear provides consumers and professionals excellent alternatives to harmful rodenticides and insecticides. For more information, visit www.ecoclearproduct.com/pro.
Contact Information:
Maria Penaloza
Press Release Service
by
Newswire.com
Original Source:
EcoClear’s ProBio® OdorOut® Targets, Eliminates Odors
Zayn Malik Reveals How Simon Cowell Destroyed Him OMG! Were you even ready for a full-blown 2021 Zayn Malik rap era? Um, Zayn’s fans were totally living for the era, especially since he spilled some serious tea on his time on One Direction and his former boss Simon Cowell So, what exactly did Zayn say […]
CCSO is proactive in working with the construction industry to guard vulnerable sites and valuable materials
NAPLES, Fla. – December 12, 2022 – (Newswire.com)
An innovative and award-winning crime prevention program is keeping construction sites safe from thieves in one of the fastest-growing areas of the country.
The Collier County Sheriff’s Office Construction Site Watch Program recently was named the Outstanding Crime Prevention Program of the Year by the Florida Crime Prevention Association. Sheriff Kevin Rambosk created the program in November 2021 to allow deputies to work closely with contractors to monitor and protect at-risk equipment and materials.
“As our area continues to grow and prosper, we are committed to preventing crimes anywhere in the county – even those places that are still being built,” Rambosk said. “The FCPA award recognizes the success of this program in identifying, preventing, investigating and minimizing construction site crime.”
Through the Construction Site Watch Program deputies are preventing crimes with a combination of community engagement, data analysis and sophisticated tracking and monitoring technology.
Located in Southwest Florida, Collier County is seeing a surge in construction because of a high demand for housing, which also leads to more commercial building. Construction sites often are targeted by criminals because they’re in remote locations, lack security and lighting, and usually have thousands of dollars of materials and equipment on hand.
The cost of materials has gone up, and supply-chain issues have created a higher demand, making construction sites even more attractive to thieves.
With the Construction Site Watch Program, the Sheriff’s Office partners with contractors to protect equipment. The program is simple and effective.
Contractors alert the Sheriff’s Office when they have materials being delivered, or when they are leaving equipment on-site. They can send pictures and serial numbers of specific items they would like monitored.
CCSO’s Real-Time Operations Center (ROC) compiles a watchlist of vulnerable locations. That list is then sent to deputies, who closely monitor these sites by visiting the locations daily. The ROC uses geo-fencing capabilities to accurately track site checks.
If deputies discover that something is missing, they have the contact information for the supervisor at each location and can contact them immediately.
CCSO Crime Prevention deputies have been proactive about bringing awareness to this program and ensuring that construction companies take advantage of the resource. Deputies visit with contractors at offices, industry meetings and forums, and even on sites to distribute literature with program information. CCSO also educates the companies about trends and thefts in the construction industry.
Through this program, the Sheriff’s Office has developed an effective, long-lasting and significant strategy to reduce construction site thefts.
Contact Information:
CCSO Media Relations Bureau
239-252-0608
Press Release Service
by
Newswire.com
Original Source:
Collier Co. Sheriff’s Office Curbs Construction Thefts With Award-Winning Crime Prevention Program
The specialized ultrasound treatment is now available to medical professionals across the United States.
sam\u00ae home use treatment for knee pain…
Read More
New Mandibular Advancement Device Provides Dentists with an Innovative 3D-Printed Option to Treat Patients with Sleep Apnea
New West Dental Lab Int…
Read More
AdventHealth is taking its Nursing Professional Excellence Program digital with StaffGarden’s cloud-based Clinical Ladder Platform Grow
FULLERTON, Calif. – December 12, 2022 – (Newswire.com)
StaffGarden, the leader in software development supporting professional advancement programs such as clinical ladder programs that help nurses advance in their careers, is announcing a year-long partnership with the faith-based healthcare system AdventHealth. AdventHealth has more than 50 hospitals and hundreds of care sites in almost a dozen states, with 6.8 million patient interactions annually.
The clinical ladder is a structured system, traditionally on paper, to support nurses’ career advancement while remaining in their current clinical setting, providing direct patient care.
Digitizing the clinical ladder in healthcare systems to promote nurse engagement has been overlooked in the industry. Grow, from StaffGarden, has stepped in and given nurses a better way to advance their careers by providing software that organizes materials in one centralized hub while tracking engagement. StaffGarden provides innovative technology solutions to over 800 facilities nationwide and will expand further in 2023.
“AdventHealth is an excellent partner to work with,” Brian Card, StaffGarden’s Vice President, said. “It’s truly impressive to see our product impact the healthcare industry, helping nurses progress in their careers and assisting health systems with engagement and retention at such a critical time.”
AdventHealth chose the StaffGarden Grow platform in early 2022 to launch its Professional Excellence Program across the system throughout 2022 and 2023. AdventHealth began with its direct care nurses and later expanded to a second program for assistant nurse managers.
“StaffGarden’s platform has been integral to the successful launch of our national Nursing Professional Excellence Program. It supports the professional development needs of our nursing workforce. The platform is intuitive and makes it easy for our nurses to input the documentation supporting their work,” said Trish Celano, Chief Nurse Executive for AdventHealth. “Also, the review and approval process for our nurse leaders is efficient.”
About StaffGarden
StaffGarden is the leading digital healthcare company in software development supporting Clinical Ladder, Competency Assessments, Peer Reviews, Magnet Tracking, and Portfolio Management in healthcare systems. StaffGarden is revolutionizing the way nurses track, share and manage their nursing careers. With seven years of experience, we are poised to take your clinical ladder to the next level. To learn more about StaffGarden, check us out on LinkedIn or at StaffGarden.com.
About AdventHealth
With a sacred mission of Extending the Healing Ministry of Christ, AdventHealth is a connected system of care for every stage of life and health. More than 80,000 skilled and compassionate caregivers in physician practices, hospitals, outpatient clinics, skilled nursing facilities, home health agencies, and hospice centers provide individualized, wholistic care. A shared vision, common values, focus on whole-person health, and commitment to making communities healthier unify the system’s more than 50 hospital campuses and hundreds of care sites in diverse markets throughout almost a dozen states. For more information about AdventHealth, visit AdventHealth.com/news.
Contact Information:
Brian Card
VP Sales, Marketing
(800) 671-3606
Mike Altier
Director, Marketing
(800) 671-3606
Press Release Service
by
Newswire.com
Original Source:
StaffGarden Announces Year-Long Partnership With AdventHealth
The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo’s Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samples
PHILADELPHIA – December 12, 2022 – (Newswire.com)
Senzo, a life sciences company developing high accuracy, low-cost point-of-care diagnostic technologies, today announced a $1.9 million investment led by existing investors BioAdvance and Wellness Coaches.
The funding follows recent blinded studies by UCL and LateralDx, confirming that the Senzo Amplified Lateral Flow test had 98% accuracy in comparison to PCR in correctly identifying COVID-19 virus in samples, even at very low viral loads above 30 Ct. These studies, combined with an earlier study by Sheffield University, demonstrate the high performance of the Senzo Amplified Lateral Flow (ALF) platform. ALF is the only platform that combines the speed and low cost of lateral flow tests with the accuracy of PCR tests.
The investment will be used to complete validation, execute clinical trials, secure FDA EUA authorization, and scale manufacturing for the ALF COVID-19 test, as well as to advance R&D for new Flu A/B, RSV, Tuberculosis, HIV, Hepatitis-C, and Strep tests.
“This funding further indicates the interest and excitement investors have in the ALF platform, and is another important step in bringing our technology to market. Whether for COVID-19, TB, Flu, or a range of other diseases, there are patients in desperate need of better at-home, rapid-test diagnostics, and a huge market needing our tests. This investment will help us bring this innovative technology to market even faster,” said Jeremy Stackawitz, CEO of Senzo Health.
Senzo plans to complete ALF COVID-19 clinical trials and secure FDA EUA regulatory approval in 1H 2023, with tests commercially available in the 2H 2023.
About Senzo:
Senzo is an in vitro diagnostics company developing innovative, accurate, and accessible testing products. Senzo was founded with the vision of utilizing novel technologies, with a focus on enhanced sensitivity, to create mobile, point-of-care and self-testing products and devices with the ability to accurately, quickly, and cost-effectively conduct testing where healthcare professionals and patients need it most. Senzo is creating game-changing products and systems which bring testing to the patient, eliminating the need for the current slow, expensive central-lab testing paradigms.
About BioAdvance:
BioAdvance is an early-stage life sciences fund with a focus in the mid-Atlantic region, investing up to $1.5 million initially and up to $5 million over the lifetime of companies with the potential to significantly improve human health. www.bioadvance.com.
About Wellness Coaches:
Wellness Coaches is one of the largest and most-experienced tech-enabled wellness, nutrition, clinical, and injury prevention service providers, utilizing both onsite and virtual expertise to help communities and organizations increase engagement, improve population health, mitigate safety risks, and reduce healthcare and workers’ compensation costs. www.wcusa.com.
For more information, visit https://www.senzo.com.
Press Contact:
Alex Mohacs
alex@senzo.com
Contact Information:
Alex Mohacs
Sales & Marketing
Press Release Service
by
Newswire.com
Original Source:
Senzo Secures Additional $1.9MM Equity Funding for Its PCR-Accurate Lateral Flow Test